போது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from போது சீரம் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In போது சீரம் நிறுவனம் Today - Breaking & Trending Today

Covid-19: What's India's vaccine output? There's no sure shot reply | India News

NEW DELHI: India’s junior health minister, Bharati Pravin Pawar, gave the Rajya Sabha three different sets of numbers for the monthly output of Covaxin, and two for Covishield, on the same day in response to questions.
Two of these questions were asked by the same member. And the numbers cited by the minister don’t match what the government had earlier told the Supreme Court in affidavits.
On July 20, in response to a question from Congress MP Mallikarjun Kharge, Pawar said the average monthly production capacity of Covishield by Serum Institute of India is 11 crore doses and of Covaxin by Bharat Biotech 2.5 crore doses. ....

Andhra Pradesh , Rajya Sabha , Bharati Pravin Pawar , Supreme Court , Bharat Biotech Intl Ltd , Congress Mp Mallikarjun Kharge , Serum Institute Of India Ltd , Supreme Court On , While Serum Institute , Serum Institute Of India , Serum Institute , Bharat Biotech , India Ltd , Biotech Intl , ஆந்திரா பிரதேஷ் , ராஜ்யா சபா , பாரதி பிராவின் பவார் , உச்ச நீதிமன்றம் , பாரத் பயோடெக் இந்தில் லிமிடெட் , சீரம் நிறுவனம் ஆஃப் இந்தியா லிமிடெட் , உச்ச நீதிமன்றம் ஆன் , போது சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , சீரம் நிறுவனம் , பாரத் பயோடெக் , இந்தியா லிமிடெட் ,

BSL-3 labs: Why India needs more of them to brace for future pandemics

BSL-3 labs: Why India needs more of them to brace for future pandemics
indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.

Madhya Pradesh , United States , United Kingdom , Andhra Pradesh , Sierra Leone , Chandrakant Lahariya , National Institute Of Virology , University Of Oxford , Technology Department Of Biotechnology , Us Centers For Disease , World Health Organisation , National Institute Of Mental Health , European Union , Serum Institute , National Institute Of High Security Animal Diseases , While Serum Institute , Wuhan Institute Of Virology , High Security Animal Disease Laboratory , Ministry Of Science , Pune Based Serum Institute , Hyderabad Based Bharat , Bharat Biotech , Biosafety Level , National Expert Group , Vaccine Administration , Photo Credit ,

DCGI nod to Phase 2-3 clinical trials of Covaxin for 2-18 years

Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers ....

Serum Institute Of India Covishield , Bharat Biotech Ltd , Indian Council Of Medical Research , Expert Committee , While Serum Institute , Russian Direct Investment Fund , Drugs Controller General , Subject Expert Committee , Bharat Biotech , Indian Council , Medical Research , Serum Institute , Pune Based Serum Institute , Hyderabad Based Bharat Biotech , Covaxin Phase 2 Trial For Age To 18 , Covaxin Phase 3 Trial For Age 2 To 18 , Clinical Trials Of Covaxin For Children , Covaxin Vaccine For Children , Covaxin Vaccine Trial For Age 2 To 18 , பாரத் பயோடெக் லிமிடெட் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , நிபுணர் குழு , போது சீரம் நிறுவனம் , ரஷ்ய நேரடி முதலீடு நிதி , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , பொருள் நிபுணர் குழு ,

COVID-19 vaccine: SII, Bharat Biotech to raise production by August

COVID-19 vaccine: SII, Bharat Biotech to raise production by August
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August
BusinessToday.In | May 13, 2021 | Updated 09:33 IST
Serum Institute of India and Bharat Biotech have submitted their production plan for the next four months as several states continue to report the shortages of COVID-19 vaccines.
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August.
Whole-time Director of Bharat Biotech Dr V Krishna Mohan told the Union Health Ministry and the office of Drugs Controller General of India (DCGI) that the production of Covaxin can be raised to 3.32 crore in July and 7.82 crore in August, which will also be maintained in September. ....

Uttar Pradesh , Andhra Pradesh , V Krishna Mohan , Union Health Ministry , Department Of Pharmaceuticals Rajneesh Tingal , While Serum Institute , Serum Institute Of India , Ministry Of Science , Health Ministry Dr Mandeep Bhandari , Serum Institute , Bharat Biotech , Pune Based Serum Institute , Hyderabad Based Bharat Biotech , Bharat Biotech Drv Krishna Mohan , Drugs Controller General , Regulatory Affairs , Serum Institute Prakash Kumar Singh , Joint Secretary , Pharmaceuticals Rajneesh Tingal , Covid 19 Vaccine , Covid 19 Vaccine Production , Serum Institute Of India Covid 19 Vaccine , Bharat Biotech Covid 19 Vaccine , Sii Covid 19 Vaccine , Serum Institute Covid 19 Vaccine , Serum Institute Of Ind ,

Bharat Biotech commences direct supply of 'Covaxin' to 14 states

Hyderabad-based vaccine manufacturer Bharat Biotech has been supplying Covaxin its Covid-19 vaccine directly to 14 states beginning May 1.
According to a tweet by the company’s joint managing director Suchitra Ella, Bharat Biotech has been supplying Covaxin to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
Ella said in the tweet, “Glad to announce that Bharat Biotech confirms direct supplies of COVAXIN to the following state govt’s since 1/5/21, based on the allocations received by the GoI. Requests have been received from other states, and will be processed for distribution based on availability of stocks 24x7.” ....

Jammu And Kashmir , Madhya Pradesh , Andhra Pradesh , Tamil Nadu , Uttar Pradesh , Suchitra Ella , Serum Institute , While Serum Institute , Bharat Biotech , ஜம்மு மற்றும் காஷ்மீர் , மத்யா பிரதேஷ் , ஆந்திரா பிரதேஷ் , தமிழ் நாடு , உத்தர் பிரதேஷ் , சூச்சித்ர எல்லா , சீரம் நிறுவனம் , போது சீரம் நிறுவனம் , பாரத் பயோடெக் ,